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Abstract
Background: Diagnostic decisions in clinical imaging currently rely almost exclusively on visual
image interpretation. This can lead to uncertainty, for example in dementia disease, where some
of the changes resemble those of normal ageing. We hypothesized that extracting volumetric data
from patients' MR brain images, relating them to reference data and presenting the results as a
colour overlay on the grey scale data would aid diagnostic readers in classifying dementia disease
versus normal ageing.
Methods: A proof-of-concept forced-choice reader study was designed using MR brain images
from 36 subjects. Images were segmented into 43 regions using an automatic atlas registration-
based label propagation procedure. Seven subjects had clinically probable AD, the remaining 29 of
a similar age range were used as controls. Seven of the control subject data sets were selected at
random to be presented along with the seven AD datasets to two readers, who were blinded to
all clinical and demographic information except age and gender. Readers were asked to review the
grey scale MR images and to record their choice of diagnosis (AD or non-AD) along with their
confidence in this decision. Afterwards, readers were given the option to switch on a false-colour
overlay representing the relative size of the segmented structures. Colorization was based on the
size rank of the test subject when compared with a reference group consisting of the 22 control
subjects who were not used as review subjects. The readers were then asked to record whether
and how the additional information had an impact on their diagnostic confidence.
Results: The size rank colour overlays were useful in 18 of 28 diagnoses, as determined by their
impact on readers' diagnostic confidence. A not useful result was found in 6 of 28 cases. The impact
of the additional information on diagnostic confidence was significant (p < 0.02).
Conclusion: Volumetric anatomical information extracted from brain images using automatic
segmentation and presented as colour overlays can support diagnostic decision making.
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During the last four decades, numerous efforts have been
directed at developing computer-assisted diagnosis and
making such methods usable in practice [1]. The promise
is that computer-assisted diagnosis will increase screening
capacities, reduce the problem of observer dependence
and increase diagnostic accuracy in imaging. Most of these
developments are centred around algorithms that identify
patterns suggestive of disease in two-dimensional (2D)
images. Some success has been achieved in mammogra-
phy (detecting massses and clustered microcalcifications),
chest radiography (lung nodules and vertebral fractures),
and magnetic resonance angiography (intracranial aneu-
rysms) [2]. Implementing a technical system that per-
forms generic pattern recognition is fraught with
algorithmic challenges. The conjecture behind our work is
that decision support systems which complement human
pattern recognition capabilities, rather than attempting to
supplant them, will prove to be more useful and could
have a major impact on clinical radiology and imaging
research.
Brain imaging lends itself particularly well to investigating
and developing this potential. A large body of published
research exists on the computational problems of tissue
classification, registration and atlas label propagation.
The resulting capabilities have been applied in neurologi-
cal science, for example for discovering relationships
between brain structure and neurological function. The
potential benefits of these advanced image processing
methods for clinical diagnostic radiology are underex-
plored in comparison. In the current paradigm, clinical
diagnosis generally relies on visual assessment of 2D sec-
tions calculated from the data, even when three-dimen-
sional (3D) volumes have been acquired. The expert
diagnostic reader forms a 3D mental representation of a
patient's anatomy based on pixel intensities and com-
pares this representation with a learned model of normal
anatomy. The validity of the resulting interpretation
depends on the reader's experience and the type and stage
of pathology present. Neurodegenerative disease can be
particularly difficult to detect, with low levels of interob-
server agreement, especially when comparing inexperi-
enced with experienced readers [3]. In some entities,
notably Alzheimer disease (AD), typical findings can be
difficult to distinguish from dynamic alterations in nor-
mal ageing [4].
When pathological change is complex, distributed, and
symmetric, the relatively poor performance of human
observers is in part explained by the difficulty of assessing
structure volumes from sectional images. A volume
increase by a factor of two in a hypothetical spherical
structure would be reflected by an increase of the radius of
only circa 26 %. An arbitrary change in the through-plane
dimension of a structure goes completely unnoticed on a
single sectional image.
Image data displays that combine information from dif-
ferent modalities by overlaying false colour are common-
place [5]. Structural grey scale ultrasound images, for
example, are routinely supplemented in clinical practice
with functional information determined using Doppler
blood flow measurements and presented as colour over-
lays. Similarly, other combinations of structural and func-
tional imaging modalities are used to produce "fusion"
images. Reports where such an approach has been used to
enhance the diagnostic value of structural images with
computationally derived comparison measures [6] are
surprisingly scarce.
A procedure that could reliably extract volumetric infor-
mation from a target image and present it in an integrated
fashion could complement human capabilities in diag-
nostic imaging. We hypothesized that using automatic
segmentation and comparative volumetric information
presented as colour overlays on sectional images can
improve confidence in the diagnosis of AD. We tested this
hypothesis in a forced-choice reader study.
Methods
Study data
MR images from a cohort of 36 subjects (age 72.5 ± 8
years), who had taken part in a previous study on AD
undertaken by the Oxford Project to Investigate Memory
and Aging (OPTIMA), were available for this work. Seven
of these subjects (age range 57 to 82 years) were classed as
affected by AD according to NINCDS criteria [7] (possible
disease, n = 2; probable disease, n = 5). Beyond this clas-
sification, no individual data on the clinical status was
available. The remaining 29 subjects were of comparable
age (range 54 to 77 years) and did not meet clinical crite-
ria for AD. In the OPTIMA study, volume images with a
spatial resolution of 1 mm3 had been acquired using T1-
weighted sequences. Participants in the study had given
informed consent to the scientific use of their clinical and
imaging data. OPTIMA protocols have been described
previously [8] and were approved by the Central Oxford
Research Ethics Committee.
Anatomical segmentation
The study data sets were segmented into anatomically
defined regions of interest (ROI) through atlas label prop-
agation. The atlas used was a labelled MR data set
obtained from the Internet Brain Segmentation Reposi-
tory, provided by the Center for Morphometric Analysis
(CMA) at Massachusetts General Hospital [9]. The MR
image had been segmented manually into 43 structures by
a trained expert using a guided procedure [10]. The seg-
mentation was supplied as a separate label set that corre-Page 2 of 6
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values linked to the name of a region via a lookup table.
The label propagation procedure was equivalent to the
single-atlas method described in [11], consisting of skull
stripping, affine registration and nonrigid registration
using multi-resolution free-form deformations down to a
control point spacing of 2.5 mm. The output was used to
transform the atlas label set into the space of the target
subject.
Comparative volumetry
The seven AD subjects, together with seven randomly cho-
sen normal study subjects from the OPTIMA cohort, were
used as the test subject cohort. The remaining 22 normal
study subjects were used as the reference cohort, provid-
ing a measure of normality that the test subjects could be
compared against. For each ROI, and for each test subject
in turn, rank tables were generated, showing the relative
size of the test subject's ROI as a rank number from 1 to
23 (22 control and one test subject). Colour overlays were
generated for each test subject using pre-defined lookup
tables. The colour scheme used was as follows: ranks 1 to
4 were shown in shades of yellow, 5 to 9 in shades of red,
10 to 13 fully transparent, 14 to 18 shown in shades of
blue and 19 to 23 in shades of cyan (Figure 1). The highest
and lowest ranks were thus coloured brightly, while struc-
tures in the mid-range of the size rank order were not col-
oured at all.
Visual review
All 14 test subjects were reviewed by a neuroradiologist
and a general radiologist. They were informed of the sub-
jects' age, sex and number of AD (7/14) and control cases
(7/14) in the group, but were blinded to the individual
diagnosis and other clinical information. Readers made a
forced-choice classification of AD versus non-AD findings
based on reviewing the unmodified grey scale images. The
choice was recorded. Readers were then asked to rate their
confidence in this diagnosis on a scale from 1 to 10. After-
wards, the size rank colour overlay was made available to
be turned on and off as required by the reader. Diagnostic
confidence was recorded again to determine the impact of
the added information. The overlay method was classified
as useful for cases where it confirmed an initially correct
assessment, and for cases where it reduced confidence in
an initially incorrect assessment. If confidence in a correct
assessment was reduced, or if confidence in an incorrect
assessment was increased, the overlay method was rated
as not useful for the case in question. An unchanged verdict
was recorded if readers recorded no change in confidence.
Results
Individual results of all 28 classifications made are shown
in Table 1. Of these, 22 were correct (80 %). The size rank
colour overlays were useful in 18 of 28 cases, as deter-
mined by their impact on readers' diagnostic confidence.
A not useful result was found in 6 of 28 cases. The differ-
ence in confidence in useful results was 1 in 11/18 cases, 2
in 5/18 cases, and 4 in 2/18 cases. The difference in confi-
dence in not useful results was 1 in 5/6 cases and 2 in 1/6
cases. The impact of the overlay on diagnostic confidence
was significant as measured by a two-tailed Wilcoxon
signed-rank test (p < 0.02).
Results by diagnosis and type of influence on diagnostic
confidence (14 subjects rated by two readers) are shown
in Table 2.
In cases of AD where the initial assessment was correct,
the readers' confidence was increased particularly if the
overlay indicated a relatively small cortex, a small hippoc-
ampus or large lateral ventricle on at least one side. Read-
ers noted that in AD the overlay looked strongly
asymmetrical, especially in the cortices, and even when
the grey scale findings did not suggest a large amount of
anatomical asymmetry. Asymmetry of the overlay was
also seen in some of the normal subjects.
In two of the subjects with AD, the cortex size was shown
to rank high. Both of these subjects had wide sulcal spaces
that were mislabelled as part of the cortex by the label
propagation process. In another case of AD, massively
large lateral ventricles were mislabelled as white matter.
One observer rated these misregistered overlays as reduc-
ing confidence, the other observer disregarded the infor-
mation pertaining to the misregistered structures and
considered only the remaining, correctly registered struc-
tures.
Discussion
This study demonstrates the utility of providing automat-
ically derived comparative volumetric information in dis-
tinguishing Alzheimer disease from normal ageing on
MRI images of the brain. Presenting this information as a
colour overlay on the grey scale sectional images
improved the diagnostic outcome. The fact that volumetry
was performed in an automated fashion using pre-pre-
pared expert input indicates that the method is scalable to
larger cohorts.
The results are novel in that they provide proof of concept
for diagnostic decision support based on brain volumetry.
In the majority of cases, we found that the colour overlays
confirmed readers' initial assessment of the plain grey
scale MR image. In a smaller number of cases, readers
made an erroneous classification and stated that, after
reviewing the colour-overlaid version of the image, they
were less confident in this assessment. In a practical set-
ting, they might have sought further information orPage 3 of 6
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Colour overlaysFigure 1
Colour overlays. Images of test subjects as shown to readers. Row a: grey scale images of a control subject. Row b: same 
sections as shown in a) with a colour overlay indicating the size rank of the labelled structures. Most structures are in the 
medium range (transparent overlay). The left cortex is among the largest, as shown by the yellow label. Row c: subject with 
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which would have been a desirable outcome.
Problematic situations arise when misregistration results
in erroneous estimation of the volumes of ROIs. Some
refinements of the automatic segmentation method
would help reduce this problem. For example, fusing mul-
tiple manual atlases [11] and atlas selection [12] can
increase segmentation accuracy substantially. Choosing
more accurate or specialized atlases as label sources is
another avenue towards increasing the potential benefit
of the approaach. In the present work, the input segmen-
tation was based on 43 regions. By using atlases based on
a stricter protocol using more and smaller ROIs [13], more
as well as more accurate information could be used to
generate the colour overlay. In [14], we showed that such
atlases and a label propagation-fusion approach provide
sufficient volumetric information to distinguish normal
from atrophic hippocampi without user intervention.
Training readers in the use of volumetry overlays is likely
to improve outcomes, as they will anticipate and recog-
nize situations where labels might be inaccurate, for
example when subject pathology prevents correct segmen-
tation. Nevertheless, the surfeit of useful over not useful
outcomes in this study indicates that even coarse compar-
ative volumetry can provide a benefit for diagnosis.
For this proof-of-concept work, we chose a subjective
measure – diagnostic confidence – and assessed the differ-
ence before and after presentation of the overlay. The
results encourage a study on larger numbers of subjects
and readers, which would allow an approach where accu-
racy of the forced choice is used as the outcome measure.
Using larger cohorts, it will be possible to eliminate the
Table 1: Per-case results
Subject Confidence before After Change Diagnosis correct Effect helpful Neutral Unhelpful
Reader 1 3 8 4 4 False 1 0 0
7 7 5 -2 true 0 0 1
12 8 8 0 true 0 1 0
14 8 4 4 false 1 0 0
17 7 8 1 true 1 0 0
19 7 8 1 true 1 0 0
20 6 8 2 true 1 0 0
27 7 6 1 false 1 0 0
29 8 8 0 true 0 1 0
31 7 7 0 true 0 1 0
32 6 7 -1 false 0 0 1
33 7 7 0 false 0 1 0
35 6 8 2 true 1 0 0
37 7 8 1 true 1 0 0
Reader 2 3 9 10 1 true 1 0 0
7 9 8 -1 true 0 0 1
12 8 9 1 true 1 0 0
14 8 9 1 true 1 0 0
17 8 9 1 true 1 0 0
19 8 9 1 true 1 0 0
20 8 9 1 true 1 0 0
27 7 9 2 true 1 0 0
29 8 7 -1 true 0 0 1
31 7 9 2 true 1 0 0
32 8 9 -1 false 0 0 1
33 6 8 2 true 1 0 0
35 9 10 1 true 1 0 0
37 8 7 -1 true 0 0 1
Sum 22 18 4 6




Diagnosis correct 15 3 4
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potential bias resulting from readers' expectations or
desire for a particular outcome of the study by presenting
additional subgroups with "mock" overlays containing
randomly assigned colours.
The small number of subjects used for this study also
meant that no stratification according to the severity of
disease-related change in the subjects was possible. Com-
parative volumetry would be particularly useful if its
impact was present in patients with early disease, where
interrater variability is particularly high [4]. We aim to
address this question in future work.
Another limitation of this study is that readers were
merely offered an explanation of how the overlay was gen-
erated, while no examples were shown and no opportu-
nity for practice was given. As readers learn to integrate the
extra information provided by the overlay, the influence
on their diagnostic decision is likely to evolve. Again,
given larger subject numbers, it would have been possible
to include a practice phase in the study design, which
would have minimized any distortion of the results aris-
ing from readers' skill development in using the colour
overlays.
Conclusion
The results of this study indicate that an integrated presen-
tation of comparative volumetry results can support diag-
nostic decision making in imaging of neurodegenerative
disease.
Outside the realm of clinical imaging, similar tools could
aid drug discovery by providing better surrogate end-
points for measuring effects of candidate treatments [15].
In imaging research, the possibility of uncovering struc-
tural change or patterns of change too subtle to detect vis-
ually could aid in the detection of patterns of progression,
risk factors and prognostic indicators [16].
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